SEARCH

SEARCH BY CITATION

References

  • [1]
    Schaberg, D.R., Culver, D.H., Gayner, R.P. (1991) Major trends in the microbial etiology of nosocomial infection. Am. J. Med. 16, 72S75S.
  • [2]
    Shepherd, M.G., Poulter, R.T.M., Sullivan, P.A. (1985) Candida albicans: biology, genetics, and pathogenicity. Ann. Rev. Microbiol. 39, 579614.
  • [3]
    Blizzard, R.M., Gibbs, J.A. (1968) Candidiasis: studies pertaining to its association with endocrinopathies and pernicious anemia. Pediatrics 42, 231237.
  • [4]
    Stephens, J.M., Sulway, M.J., Watkins, P.J. (1971) Diabetes 20, 485489.
  • [5]
    Bach, M.C., Sahyoun, A., Adler, J.L., et al (1973) High incidence of fungus infections in renal transplantation patients treated with antilymphocyte and conventional immunosuppression. Transpl. Proc. 5, 549553.
  • [6]
    Cho, Y.S., Choi, H.Y. (1979) Opportunistic fungal infection among cancer patients. A ten year autopsy study. Am. J. Clin. Pathol. 72, 617621.
  • [7]
    Lehrer, R.I., Cline, M.J. (1969) Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection. J. Clin. Invest. 48, 14781488.
  • [8]
    Klebanoff, S.J. (1968) Myeloperoxidase-halide-hydrogen peroxide antibacterial system. J. Bacteriol. 95, 21312138.
  • [9]
    Klebanoff, S.J. (1972) The myeloperoxidase mediated antimicrobial systems. In: Phagocytic Mechanisms in Health and Disease (Friderberg, H.H., Ed.), pp. 3–17. Williams, New York.
  • [10]
    Klebanoff, S.J. and Clark, R.A. (1978) In: The Neutrophil: Function and Clinical Disorders, Chap. 7, pp. 409–488. North-Holland, Amsterdam.
  • [11]
    Klebanoff, S.J. (1980) Oxygen metabolism and the toxic properties of phagocytes. Ann. Intern. Med. 93, 480489.
  • [12]
    Klebanoff, S.J. (1991) Myeloperoxidase: occurrence and biological function. In: Peroxidases in Chemistry and Biology (Everse, J., Everse, K.E. and Grisham, M.B., Eds.), pp. 1–35. CRC Press, Inc., Boca Raton, FL.
  • [13]
    Wright, C.D., Nelson, R.D. (1985) Candidacidal activity of myeloperoxidase: therapeutic influence of the enzyme in vivo. Infect. Immun. 47 (2), 363365.
  • [14]
    Babior, B.M. (1984) Oxidants from phagocytes: agents of defense and destruction. Blood 64 (5), 959966.
  • [15]
    Harrison, J.E., Schultz, J. (1976) Studies on the chlorinating activity of myeloperoxidase. J. Biol. Chem. 251, 13711374.
  • [16]
    Foote, C.S., Goyne, T.E., Lehrer, R.I. (1981) Assessment of chlorination by human neutrophils. Nature (London) 301, 715716.
  • [17]
    Tobler, A. and Koeffler, H.P. (1991) Myeloperoxidase: localization, structure, and function. In: Blood Cell Biochemistry 3: Lymphocytes and Granulocytes (J.R. Harris, Ed.), pp. 255–288. Plenum Press, New York.
  • [18]
    McRipley, R.J., Sbarra, A.J. (1967) Role of the phagocyte in host-parasite interactions. XII. Hydrogen peroxide-myeloperoxidase bactericidal system in the phagocyte. J. Bacteriol. 94, 1425.
  • [19]
    Jack, M., Wood, B.J., Berry, D.R. (1990) Evidence for the involvement of thiocyanate in the inhibition of Candida albicans by Lactobacillus acidophilus. Microbios 62 (250), 3746.
  • [20]
    Fitzsimmons, N., Berry, D.R. (1994) Inhibition of Candida albicans by Lactobacillus acidophilus: evidence for the involvement of a peroxidase system. Microbios 80 (323), 125133.
  • [21]
    Harrison, J.E., Saeed, F.A. (1981) Acetoacetate is an electron donor to myeloperoxidase and a promoter of myeloperoxidase-catalyzed fatty acid peroxidation. Biochem. Med. 26, 339355.
  • [22]
    Harrison, J.E., Saeed, F.A. (1983) Radical acetoacetate oxidation by myeloperoxidase, lactoperoxidase, prostaglandin synthetase, and prostacyclin synthetase: implications for atherosclerosis. Biochem. Med. 29, 149163.
  • [23]
    Harrison, J.E. and Saeed, F.A. (1981) Acetoacetate: An Electron Donor and Halogen Acceptor for Neutrophil Myeloperoxidase and a Promoter of Fatty Acid Peroxidation. ACS Meeting Abstracts (#116), Minneapolis, MN.
  • [24]
    Saeed, F.A. and Castle, G. (1997) Neutrophil Inhibition by Acetoacetate. ASM Annual Meeting Abstracts.
  • [25]
    Saeed, F.A., Castle, G. (1998) Neutrophil chemiluminescence during phagocytosis is inhibited by abnormally elevated levels of acetoacetate: implications for diabetic susceptibility to infections. Clin. Diagn. Lab. Immunol. 5 (5), 740743.
  • [26]
    Rhoades, R.A. and Pflanzer, R.G. (1996) Human Physiology, p. 513. Saunders College Publishing, New York.